High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2

We recently characterized three FGF-binding proteins (FGF-BPs) which are soluble forms of the extracellular domains of the high affinity FGF receptors (Hanneken, A. M., W. Ying, N. Ling, and A. Baird. Proc. Natl. Acad. Sci. USA. 1994. 91:9170-9174). These proteins circulate in blood and have been proposed to modulate the biological activity of the FGF family of proteins. Immunohistochemical studies now demonstrate that these soluble, truncated FGF receptors are also present in the basement membranes of retinal vascular endothelial cells. These immunoreactive proteins can be detected with antibodies raised to the extracellular domain of FGFR-1 but not with antibodies raised to either the juxtamembrane domain or the cytoplasmic domain of FGFR-1. Western blotting of human retinal extracts with the antibody raised to the extracellular domain of FGFR-1 detects specific, low molecular mass proteins at 85 kD and 55 kD, corresponding in size to the FGF-BPs, which are not detected with antibodies against the cytoplasmic domain of the receptor. The interaction of this receptor with the extracellular matrix is not dependent on the presence of FGF-2. Immunoreactive receptors are still detected in vascular basement membranes after the removal of FGF-2 with heparitinase. In addition, the recombinant extracellular domain of FGFR-1 continues to bind to corneal endothelial cell matrix after endogenous FGF-2 has been removed with 2 M NaCl. Acid treatment, which has been shown to disrupt protein interactions with the extracellular matrix, leads to a significant reduction in the presence of the matrix form of the FGF receptor. This loss can be restored with exogenous incubations of the recombinant extracellular domain of FGFR-1. This report is the first demonstration that a truncated form of a high affinity growth factor receptor can be localized to the extracellular matrix. These findings add to the list of binding proteins associated with the extracellular matrix (IGFBP-5) and suggest a potentially new regulatory mechanism for controlling the biological availability of FGF, and other peptide growth factors, in the extracellular matrix.

[1]  N. Ling,et al.  Identification of soluble forms of the fibroblast growth factor receptor in blood. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[3]  S. Werner,et al.  A naturally occurring secreted form of fibroblast growth factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF. , 1992, The Journal of biological chemistry.

[4]  A. Baird,et al.  Immunolocalization of basic fibroblast growth factor: dependence on antibody type and tissue fixation. , 1992, Experimental eye research.

[5]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[6]  J. Dipersio,et al.  Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. de Juan,et al.  Altered distribution of basic fibroblast growth factor in diabetic retinopathy. , 1991, Archives of ophthalmology.

[8]  S. Mohan,et al.  Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. , 1991, Biochemical and biophysical research communications.

[9]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[10]  M. Kan,et al.  Fibroblast growth factor receptors from liver vary in three structural domains. , 1991, Science.

[11]  N. Yamaguchi,et al.  Molecular cloning and expression of the murine interleukin‐5 receptor. , 1990, The EMBO journal.

[12]  S. Nagata,et al.  Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Johnson,et al.  Diverse forms of a receptor for acidic and basic fibroblast growth factors , 1990, Molecular and cellular biology.

[14]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[15]  A. Isacchi,et al.  Complete sequence of a human receptor for acidic and basic fibroblast growth factors. , 1990, Nucleic acids research.

[16]  S. Ziegler,et al.  Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily , 1990, Cell.

[17]  A. Baird,et al.  Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues , 1990, The Journal of cell biology.

[18]  R. Leimgruber,et al.  Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. , 1989, The Journal of biological chemistry.

[19]  D. S. Mcleod,et al.  Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina , 1989, Journal of cellular physiology.

[20]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[21]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[22]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[23]  L. Tang,et al.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.

[24]  Masaki Yanagishita,et al.  Isolation and characterization of proteoglycans. , 1994, Methods in enzymology.

[25]  P. Barr,et al.  Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. , 1991, Growth factors.

[26]  D. Heinegård,et al.  [17] Isolation and characterization of proteoglycans , 1987 .